beta-D-ribopyranose tetrakis(3,4,5-trihydroxybenzoate)

ID: ALA383459

Chembl Id: CHEMBL383459

PubChem CID: 11600236

Max Phase: Preclinical

Molecular Formula: C33H26O21

Molecular Weight: 758.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O[C@@H]1OC[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1

Standard InChI:  InChI=1S/C33H26O21/c34-14-1-10(2-15(35)23(14)42)29(46)51-22-9-50-33(54-32(49)13-7-20(40)26(45)21(41)8-13)28(53-31(48)12-5-18(38)25(44)19(39)6-12)27(22)52-30(47)11-3-16(36)24(43)17(37)4-11/h1-8,22,27-28,33-45H,9H2/t22-,27-,28-,33+/m1/s1

Standard InChI Key:  XQNFOUUSFRMWPI-CPSNIHODSA-N

Associated Targets(Human)

ANTXR2 Tchem Anthrax toxin receptor 2 (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

3T3-L1 (3664 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 758.55Molecular Weight (Monoisotopic): 758.0967AlogP: 1.34#Rotatable Bonds: 8
Polar Surface Area: 357.19Molecular Species: NEUTRALHBA: 21HBD: 12
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.55CX Basic pKa: CX LogP: 4.04CX LogD: 3.74
Aromatic Rings: 4Heavy Atoms: 54QED Weighted: 0.07Np Likeness Score: 0.66

References

1. Ren Y, Himmeldirk K, Chen X..  (2006)  Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues.,  49  (9): [PMID:16640344] [10.1021/jm060087k]
2. G-Doyagüez E, Carrero P, Madrona A, Rodriguez-Salamanca P, Martínez-Gualda B, Camarasa MJ, Jimeno ML, Bennallack PR, Finnell JG, Tsang TM, Christensen KA, San-Félix A, Rogers MS..  (2019)  Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.,  62  (8): [PMID:30964669] [10.1021/acs.jmedchem.8b01988]

Source